drugset / Trial / NCT02945644

Trazodone Dose Tolerance and APAP Adherence

NCT02945644

Phase 1 Suspended 45 enrolled Louis Stokes VA Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Trazodone may help obstructive sleep apnea patients to stick to their therapy, but optimal dosing is unknown. This study looks at what dose of trazodone has the best balance of potential benefits to side-effects in people with obstructive sleep apnea who are either starting on positive airway pressure therapy or not adherent to it. Participants will be randomly assigned to one of three groups: trazodone 50 mg, trazodone 100 mg, or placebo for 14 days. The investigators will monitor side-effects and adherence to positive airway pressure therapy.

Timeline

Start
2017-02-13
Primary completion
2020-09
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Trazodone Small molecule 50 mg
Comparator Trazodone Small molecule 100 mg